The purpose of this Core is to provide a state-of-the-art NMR facility and medicinal chemistry expertise for the research in this program project grant. Both aspects are linked with each other and to the research components ofthe grant. The personnel will be responsible for keeping the NMR Facility and its instruments accessible, in optimal conditions, updated, and running without interruptions. The personnel will assure that existing and newly developed experimental techniques are made fully available to all participants and outside investigators on a 24-hour basis, 365 days of the year. This requires a very significant effort given the complexity and variation ofthe facility's instrumentation, and will be achieved through a close interaction between the director of the NMR facility, Gregory Heffron, and the PI, Gerhard Wagner via frequent meetings to discuss strategies for effective and economical operation ofthe lab which houses three 500's, two 600's, one 750, one 800, and the solution part of a 900 MHz instrument. In the coming months, a new Agilent 700MHz system with a high-sensitivity cryogenic probe will be installed and made available to the participants. Thus, the core is of central importance to this program project grant, and has demonstrated the ability to operate a highly productive NMR center with minimal downtime for nearly 20 years. In addition to supporting the NMR facility the Core will support specific research objectives in this grant by supporting high-throughput screening of ICCB compound libraries, NMR-based fragment screening and measuring inter-ligand NOEs of fragments, and the chemistry effort required to link fragments and optimize HTS hits or tethered compounds. In particular, these functions within the core will support discovery and optimization of inhibitors of the bacterial non-ribosomal peptide synthetase (Enterobactin Synthetase, Component 2),the TCR signaling component (Component 3), and the pleiotropic drug resistance mechanism of pathogenic yeasts (Component 4). Dr. Nathanael Gray at Dana Farber Cancer Institute, a world expert in discovery and optimization of kinase inhibitors and other drugs, will direct the medicinal chemistry effort on these projects. Nathanael Gray and his group routinely work with investigators at Dana-Farber Cancer Institute on all aspects of small molecule probe and drug discovery from hit identification following high throughput screening to developing advanced molecules highly optimized for potency, physical properties, in vitro DMPK, and in vivo PK.

Public Health Relevance

The NMR technology provided here is key to the entire research proposed here. It links the research components. The Medicinal Chemistry expertise provided by the Core will allow utilizing the structure information ofthe large systems to develop drugs for curing human diseases

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
2P01GM047467-21A1
Application #
8533512
Study Section
Special Emphasis Panel (ZRG1-BCMB-S (40))
Project Start
Project End
Budget Start
2013-05-06
Budget End
2014-04-30
Support Year
21
Fiscal Year
2013
Total Cost
$441,655
Indirect Cost
$106,829
Name
Harvard University
Department
Type
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Sun, Zhen-Yu J; Bhanu, Meera K; Allan, Martin G et al. (2016) Solution Structure of the Cuz1 AN1 Zinc Finger Domain: An Exposed LDFLP Motif Defines a Subfamily of AN1 Proteins. PLoS One 11:e0163660
Takeuchi, Koh; Arthanari, Haribabu; Imai, Misaki et al. (2016) Nitrogen-detected TROSY yields comparable sensitivity to proton-detected TROSY for non-deuterated, large proteins under physiological salt conditions. J Biomol NMR 64:143-51
Viegas, Aldino; Viennet, Thibault; Yu, Tsyr-Yan et al. (2016) UTOPIA NMR: activating unexploited magnetization using interleaved low-gamma detection. J Biomol NMR 64:9-15
Salvi, Nicola; Papadopoulos, Evangelos; Blackledge, Martin et al. (2016) The Role of Dynamics and Allostery in the Inhibition of the eIF4E/eIF4G Translation Initiation Factor Complex. Angew Chem Int Ed Engl 55:7176-9
Nishikawa, Joy L; Boeszoermenyi, Andras; Vale-Silva, Luis A et al. (2016) Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction. Nature 530:485-9
Goricanec, David; Stehle, Ralf; Egloff, Pascal et al. (2016) Conformational dynamics of a G-protein α subunit is tightly regulated by nucleotide binding. Proc Natl Acad Sci U S A 113:E3629-38
Mallis, Robert J; Reinherz, Ellis L; Wagner, Gerhard et al. (2016) Backbone resonance assignment of N15, N30 and D10 T cell receptor β subunits. Biomol NMR Assign 10:35-9
Imai, Shunsuke; Kumar, Parimal; Hellen, Christopher U T et al. (2016) An accurately preorganized IRES RNA structure enables eIF4G capture for initiation of viral translation. Nat Struct Mol Biol 23:859-64
Coote, Paul; Bermel, Wolfgang; Wagner, Gerhard et al. (2016) Analytical optimization of active bandwidth and quality factor for TOCSY experiments in NMR spectroscopy. J Biomol NMR 66:9-20
Takeuchi, Koh; Arthanari, Haribabu; Shimada, Ichio et al. (2015) Nitrogen detected TROSY at high field yields high resolution and sensitivity for protein NMR. J Biomol NMR 63:323-31

Showing the most recent 10 out of 226 publications